Staphylococcus aureus alpha-toxin is a membrane-damaging exoprotein that oligomerizes to form transmembrane pores. Chemical modification of histidines with diethylpyrocarbonate has been shown to reduce the hemolytic activity of alpha-toxin, suggesting that one or more of the histidine residues is important for toxin function. To individually assess the functional importance of each of the four histidine residues (residues 35, 48, 144, and 259), we used oligonucleotide-directed mutagenesis of the cloned alpha-toxin gene to replace each histidine with leucine. The mutant toxins were expressed in S. aureus and evaluated for hemolytic activity in vitro and for lethality in an intraperitoneal murine model. Substitution of histidine 35 with leucine produced a mutant toxin (H35L) without hemolytic or lethal activity. Mutant toxins H48L, H144L, and H259L exhibited 7, 16, and 46%, respectively, of the hemolytic activity of wild-type toxin. Immunoblotting of purified H35L toxin incubated with liposomal membranes demonstrated intact membrane binding and hexamer formation that was clearly detectable but reduced compared with that of the wild-type toxin. This suggests that hexamer formation alone is not sufficient for the expression of alpha-toxin activity. The nature of the defect underlying the lack of activity of the H35L mutant toxin remains to be elucidated but may involve failure of the hexamer to span the lipid bilayer to form a transmembrane pore or a change in the internal surface and permeability characteristics of the pore.
Staphylococcal alpha-toxin is a cytolytic exoprotein produced by most pathogenic strains of Staphylococcus aureus and is considered a major virulence factor (1, 20) . This poreforming toxin has been well characterized in the laboratory as a potent hemolysin and as a causative factor in dermonecrosis and lethality in laboratory animals (7, 26) . In addition, it exerts cytotoxic effects on mammalian cells such as cultured endothelial cells (28) , human platelets (4) , and human monocytes (3) .
The cytolytic property of alpha-toxin has been studied extensively in rabbit erythrocytes and in artificial membrane systems (11, 14, 27) . There is general agreement that pore formation is a sequential process involving hexamer assembly from monomeric toxin units. The molecular domains or residues required for these events have not been identified definitively despite previous studies which have involved the use of monoclonal antibodies against peptide domains (13, 16) and chemical modification (8, 9) .
The alpha-toxin gene has been cloned, and the DNA and amino acid sequences have been reported (12) and revised (30) . The polypeptide chain consists of 293 amino acid residues with four histidines located in positions 35, 48, 144, and 259. Chemical modification of the histidine residues of alpha-toxin by diethylpyrocarbonate results in reduced hemolytic activity (23) . Both membrane binding and oligomerization appear to be impaired. However, the relative contribution of each histidine in the events leading to transmembrane pore formation and the relevance to in vivo toxicity have not been determined. Oligonucleotide (25) .
Construction of S. aureus clones. To construct S. aureus strains which produced the mutant toxins, we used a protocol similar to that of Fairweather et al. in generating the E. coli-S. aureus shuttle plasmid pDU1212, which carries wild-type hla (10) . First, the 3.0-kb HindIII-EcoRI fragment containing a mutagenized hla (mhla) gene was ligated to pBR322. An E. coli-S. aureus shuttle vector plasmid was then formed in E. coli MV1190 by ligation of the pBR322-mhla construct to the 3.0-kb HindIll fragment of pCW59, an S. aureus-B. subtilis shuttle plasmid encoding chloramphenicol resistance. The recombinant shuttle vector containing mhla was harvested, purified, and transformed via protoplasts into S. aureus DU1090 (hla inactivated and erythromycin resistant) by using S. aureus RN4220 as an intermediate host (21) . Chloramphenicol (10 ,ug/ml) and erythromycin (10 ,ug/ml) were used for selection of clones. Plasmid DNA from S. aureus clones was prepared by using lysostaphin and the alkaline lysis procedure (24) . Plasmids containing the mhla constructs were checked by restriction analysis for comparison with plasmid pDU1212.
Purification of wild-type and mutant alpha-toxins. S. aureus DU1090 strains which had been transformed with shuttle plasmids containing the wild-type and mutant hla were cultivated in 500 ml of tryptic soy broth for 16 h at 150 rpm at 37°C with chloramphenicol (12.5 ,ug/ml) and erythromycin (10 ,ug/ ml). Each mutant toxin was purified from culture supernatants by using the controlled-pore glass method of Cassidy and Harshman (6, 15) . After elution from the column, fractions exhibiting hemolytic activity were pooled and concentrated with a Centriprep-10 device (Amicon, Beverly, Mass.) in 0.01 M sodium phosphate buffer (pH 7.2). The specimens were analyzed for purity by using a sodium dodecyl sulfate (SDS)-12% polyacrylamide gel stained with Coomassie blue (BioRad). Protein concentration was determined by the A280, using 1.1 as the milligram-per-centimeter extinction coefficient (15) .
Hemolytic activity determination. Hemolytic titration was performed as described by Bernheimer (2) . Briefly, serial dilutions of purified toxin in 0. 24 h was used as the end point, and the time in minutes from i.p. injection until death was recorded precisely. The chi-square analysis with Yate's correction was used to determine the statistical significance of differences in the number of deaths of mice in each set. For some experiments, Kaplan-Meier plots were analyzed with NCSS software (version 5.5; Hintze JL, Kaysville, Utah), and the Peto/Wilcoxon test was used to determine the statistical significance.
RESULTS
Site-directed mutagenesis and transformations. By using oligonucleotide-directed mutagenesis, the codon for each of the four histidines of alpha-toxin was changed such that leucine was substituted, resulting in four mutant toxins (H35L, H48L, H144L, and H259L). Dideoxynucleotide sequencing confirmed these substitutions and excluded any spurious mutations elsewhere in the genes for the four mutant toxins. Each of the four mutant toxin genes and the wild-type toxin gene were incorporated individually into an E. coli-S. aureus shuttle plasmid and inserted into the alpha-toxin-negative S. aureus strain DU1090 by using protoplast transformation.
Purification of toxins. Alpha-toxin from each of the transformed DU1090 strains was purified by adsorption chromatography (6, 15 alongside the purified native alpha-toxin from the prototypic strain Wood 46 (Fig. 1) .
Hemolytic activity of wild-type and mutant alpha-toxins purified from S. aureus DU1090. The specific activities of all of the purified mutant alpha-toxins were less than that of the wild type. Wild-type toxin expressed in transformed DU1090 demonstrated a specific hemolytic activity of 26,250 HU/mg, a value comparable to those previously reported (15) . The H35L mutant toxin was devoid of hemolytic activity, with a sensitivity by this assay of less than 1 HU/mg. H48L and H144L toxins exhibited 7 and 16% of the specific activity of the wild-type toxin, respectively (i.e., 1,895 and 4,268 HU/mg of protein). H259L toxin exhibited the least reduction in hemolytic activity, with an activity of approximately 46% of that of wild-type toxin (i.e., 12,130 HU/mg of protein).
Lethal studies in mice. The lethal activities of the wild-type toxin and three of the mutant toxins (H35L, H48L, and H259L) were assessed after i.p. injections in mice (Table 1) . Four groups containing seven to eight mice in each group received 10 jig of either wild-type toxin or one of the mutant toxins. Studies were repeated on a different day, and the results were combined for analysis. Of the 16 mice that received 10 ,ug of wild-type toxin, 14 (88%) had expired by 24 h. In contrast, no deaths occurred among 16 mice that received 10 ,ug of the H35L toxin or 15 mice that received 10 ,ug of H48L toxin. Although the total number of mice that expired after receiving the H259L or wild-type toxin was identical, the time from i.p. injection until death was longer for mice receiving the H259L toxin (Fig. 2) .
Groups of eight mice were challenged further with the H35L and H48L toxins at 100-,ug doses ( Table 1 ). All of the mice that received the H35L toxin survived; however, seven of the eight mice injected with the H48L toxin expired.
Toxin assembly in liposomes. Using multilamellar liposomes composed of egg yolk phosphatidylcholine and cholesterol, we compared the membrane binding and oligomerization of wildtype toxin and H35L toxin by using SDS-PAGE immunoblotting. Polyclonal anti-alpha-toxin serum raised against S. aureus Wood 46 hexamer permitted detection of both the hexameric and monomeric forms of alpha-toxin. After incubation of 0.1 ,umol of egg yolk phosphatidylcholine-cholesterol liposomes with 5 (29) . It has been proposed that the alpha-toxin hexamer must assume a change in conformation as it penetrates the membrane, thereby exposing critical residues that serve to line the pore channel (14) . Nonlytic hexamers such as those formed by H35L toxin may not be able to achieve the necessary change in conformation to penetrate the membrane sufficiently or may alter the electrostatic forces of the pore channel such that it remains closed. In addition, H35L toxin may also form unstable membrane-bound hexamers since moderately reduced hexamer formation was observed in the model membrane system when compared with that of the wild type.
Our data show that histidine 35 of alpha-toxin is critical to the biological activity of alpha-toxin. Clearly, other studies are needed to define the structure of hexameric transmembrane pores. The availability of these mutant toxins and the creation of others from other single amino acid substitutions should aid in determining structure-function relationships of alpha-toxin on a molecular level.
